FDA Moves to Pull Avastin Breast Cancer Approval
Links shared publicly online about this topic.
- 648total visits
FDA Moves to Pull Avastin Breast Cancer Approval
View full resource at webmd.com
Tags: Cancer, Breast Cancer, Metastatic Breast Cancer, Colorectal Cancer Medication, Women's Health, FDA, Avastin
Most Recently Shared on December 17, 2010 at 2:56 pm By:
FDA Moves to Pull Avastin Breast Cancer Approval http://bit.ly/hvaepP
Also Shared By:
New Avastin tests add to confusion over use in breast cancer - latimes.com
latimes.com — “After the FDA pulled its approval for Avastin in metastatic breast cancer cases in November, a couple of new studies offer hints of hope for its use in early-stage breast cancer.” View full resource at latimes.com
Most Recently Shared on January 28, 2012 at 3:09 am By:
Google News: New Avastin tests add to confusion over use in breast cancer - Los Angeles: http://t.co/U49t1gMv Full http://t.co/sJPQq0Rn
FDA Pulls Approval Of Avastin For Breast Cancer : Shots - Health Blog : NPR
npr.org — “After more than a year of deliberations and an unprecedented public hearing in June, the agency has revoked approval of the biotech blockbuster Avastin, a medicine that chokes off the blood supply to various cancer cells, as a treatment for metastatic breast cancer.” View full resource at npr.org
Most Recently Shared on November 25, 2011 at 8:15 pm By:
FDA Pulls Approval Of Avastin For Breast Cancer, Dr. Sekeres weighs in. http://t.co/pKxnsPEt @nprhealth
Roche’s Avastin Revoked for Use in Breast Cancer, FDA Says - Businessweek
businessweek.com — “U.S. regulators revoked approval of Roche AG’s Avastin as a treatment for metastatic breast cancer, a move the drugmaker has said could put as much as 800 million Swiss francs ($873 million) in revenue at risk.” View full resource at businessweek.com
Most Recently Shared on November 24, 2011 at 1:49 am By:
Roche’s Avastin Revoked for Use in Breast Cancer, FDA Says: U.S. regulators revoked approval of Roche AG’s Avast... http://t.co/wiOduoUi
FDA's Avastin decision sends breast cancer patients reeling - HealthPop - CBS News
cbsnews.com — “Agency pulls blockbuster drug's approval for breast cancer, saying evidence doesn't confirm benefit Read more by David W Freeman on CBS News' HealthPop.” View full resource at cbsnews.com
Most Recently Shared on November 19, 2011 at 6:03 am By:
FDA revokes approval of drug for breast cancer http://t.co/kEBh5xzX via @cnet
FDA rejects Avastin for use against metastatic breast cancer – The Chart - CNN.com Blogs
thechart.blogs.cnn.com — “The Food and Drug Administration announced Friday that it was revoking its approval of the drug Avastin for metastatic breast cancer after concluding that it has not been shown to be safe and effective for that use.” View full resource at thechart.blogs.cnn.com
Most Recently Shared on November 18, 2011 at 8:21 pm By:
FDA rejects Avastin for use against metastatic breast cancer – The Chart - http://t.co/hROKoqgJ Blogs http://t.co/oHTUwiIC via @cnn
FDA Commissioner announces Avastin decision
fda.gov — “FDA Commissioner Margaret A. Hamburg, M.D., said today she is revoking the agency’s approval of the breast cancer indication for Avastin (bevacizumab) after concluding that the drug has not been shown to be safe and effective for that use.” View full resource at fda.gov
Most Recently Shared on November 18, 2011 at 3:38 pm By:
FDA revokes approval of Avastin for breast cancer, drug not shown to be safe and effective in breast #cancer patients http://t.co/jpnkqr6q
Pushing the envelope : Nature Biotechnology : Nature Publishing Group
nature.com — “The US Food and Drug Administration (FDA) should follow its advisory panels and rescind metastatic breast cancer from Avastin's label.” View full resource at nature.com
Most Recently Shared on August 8, 2011 at 6:57 pm By:
More on Avastin breast cancer use in Nature Biotech: If FDA doesn't pull it, fast-track approval will lose credibility. http://bit.ly/nMFiAP
Expert Panel Tells FDA To Pull Approval Of Avastin For Breast Cancer : Shots - Health Blog : NPR
npr.org — “Genentech failed to persuade a single member of the Food and Drug Administration's panel of cancer experts that its blockbuster drug Avastin should keep the agency's seal of approval for treating advanced breast cancer.” View full resource at npr.org
Most Recently Shared on June 30, 2011 at 6:15 pm By:
Genentech fails to persuade any members of #FDA panel to approve Avastin for breast cancer treatment (@nprhealth) http://n.pr/jurtgL
A.M. Vitals: FDA Panel Recommends Pulling Avastin’s Breast-Cancer Approval - Health Blog - WSJ
blogs.wsj.com — “Also: Fenugreek seeds implicated in E. coli outbreak; appeals court upholds health-care overhaul law; lower-rated hospital bonds are punished.” View full resource at blogs.wsj.com
Most Recently Shared on June 30, 2011 at 1:01 pm By:
A.M. Vitals: FDA Panel Recommends Pulling Avastin’s Breast-Cancer Approval http://on.wsj.com/iLTyBR
Expert Panel Tells FDA To Pull Approval Of Avastin For Breast Cancer : Shots - Health Blog : NPR
npr.org — “Genentech failed to persuade a single member of the Food and Drug Administration's panel of cancer experts that its blockbuster drug Avastin should keep the agency's seal of approval for treating advanced breast cancer.” View full resource at npr.org
Most Recently Shared on June 29, 2011 at 9:53 pm By:
Expert Panel Tells FDA To Pull Approval Of Avastin For Breast Cancer: Genentech failed to persuade a sing... http://n.pr/jK7pZ7 from NPR
Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No : Shots - Health Blog : NPR
npr.org — “In a controversial 2008 decision, the FDA gave a fast-track approval for the pricey drug for breast cancer treatment based on a single study. Now, after subsequent research proved disappointing, the agency is moving to revoke the approval, angering patients and the drug's maker.” View full resource at npr.org
Most Recently Shared on June 29, 2011 at 2:31 pm By:
Commentary: Avastin as breast #cancer treatment tests US #FDA's ability to say no http://n.pr/lLx8Cu - Well said: "Do data matter?" #health
Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No : Shots - Health Blog : NPR
npr.org — “In a controversial 2008 decision, the FDA gave a fast-track approval for the pricey drug for breast cancer treatment based on a single study. Now, after subsequent research proved disappointing, the agency is moving to revoke the approval, angering patients and the drug's maker.” View full resource at npr.org
Most Recently Shared on June 29, 2011 at 2:03 pm By:
From @dickknox: Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No http://n.pr/koGuyf
FDA Revokes Approval for Breast Cancer Drug
healthbistro.lifescript.com — “In what many feel is a sign of the times to come, the Food and Drug Administration (FDA) has moved to revoke regulatory approval for Avastin, an innovative biotech treatment for metastatic breast cancer. The FDA announced that the risks” View full resource at healthbistro.lifescript.com
Most Recently Shared on December 27, 2010 at 10:38 am By:
FDA Revokes Approval for Breast Cancer Drug http://bit.ly/gZvLAW
GoErie.com: Health - Health news in brief
goerie.com — “The Food and Drug Administration Thursday took the first step toward revoking approval of the blockbuster cancer drug Avastin for use against breast cancer -- an approval initially given under a special accelerated evaluation process that was always subject to review. Regulators pointed to four recent studies that showed Avastin did not prolong the lives of breast cancer patients. Janet Woodcock, head of FDA's drug approval office, said the agency was moving away from its earlier approval of Ava” View full resource at goerie.com
Most Recently Shared on December 20, 2010 at 10:07 am By:
Health news in brief: The Food and Drug Administration Thursday took the first step toward revoking approval of ... http://bit.ly/fA6MEQ
Advertisement


WebMD
@WebMD
FDA Moves to Pull Avastin Breast Cancer Approval http://bit.ly/hvaepP
1 year ago...